Use of PRP in Open Surgery for Type A Aortic Dissection

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

October 31, 2028

Conditions
Aortic Dissection Type ATransfusionsPlatelet Rich Plasma (PRP)Organ Protection
Interventions
BIOLOGICAL

Autologous Platelet Rich Plasma

Platelet apheresis was initiated immediately after central venous catheterization and completed before systemic heparinization using the XTRA system (LivaNova, UK). Whole blood was collected at \~60 mL/min via central venous access, \~300 mL per cycle, anticoagulated with sodium citrate. After separation, autologous platelet rich plasma and concentrated RBCs were obtained. The process was repeated for 4-6 cycles, collecting plasma equal to \~20-30% of estimated blood volume (Nadler formula). Crystalloids or colloids were infused during the procedure, and RBCs from the prior cycle were reinfused to maintain hemodynamic stability. Platelet rich plasma was stored in collection bags, agitated at room temperature, and reinfused after heparin neutralization .

PROCEDURE

Standard Blood Management

Perioperative transfusion is based on intraoperative hemodynamics and internal environment. Routine blood salvage is performed, with tranexamic acid given throughout (30 mg/kg IV loading dose, 16 mg/kg/h IV maintenance, 2 mg/kg for CPB priming). CPB is primed with 1500 ml using an integrated oxygenator, without ultrafiltration emphasis. At surgery's end, heparin-protamine neutralization is guided by a decision-making system, with point-of-care coagulation monitoring to selectively transfuse blood products based on coagulation abnormalities.

All Listed Sponsors
collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Guangzhou First People's Hospital

OTHER

lead

Beijing Anzhen Hospital

OTHER

NCT07005661 - Use of PRP in Open Surgery for Type A Aortic Dissection | Biotech Hunter | Biotech Hunter